ClinicalTrialsFinder

Recurrent or Refractory B-cell Non Hodgkin's Lymphoma Clinical Trials in Hefei, Anhui

1 recruitingHefei, Anhui, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma

Recurrent or Refractory B-cell Non Hodgkin's Lymphoma
The First Affiliated Hospital with Nanjing Medical University10 enrolled1 locationNCT06503211